B. Riley Financial Varied
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Nasdaq Biotechnology Ishares ETF (NQ: IBB )

138.86 UNCHANGED
Streaming Delayed Price Updated: 4:15 PM EDT, Jul 9, 2024 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 7
Open 138.86
Bid (Size) 138.46 (1)
Ask (Size) 139.85 (1)
Prev. Close 138.86
Today's Range 138.86 - 138.86
52wk Range 111.83 - 141.16
Shares Outstanding N/A
Dividend Yield 0.44%
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
Market Tries To Read Between The Lines
We have heard many discussions on whether small caps, like the Russell 2000 index really matter for the market. Do we care about the small caps? Is there a correction coming in large caps? 
Via Talk Markets
TSLA Hit Our Target - Here’s What’s Next
We’ll look at another big mover right now: precious metals. They still look good after Fed Chair Jerome Powell tried to talk down rate cuts today. 
Via Talk Markets
Topics Economy
Exposures Interest Rates

Performance

YTD
+0.57%
+0.57%
1 Month
+1.40%
+1.40%
3 Month
+3.42%
+3.42%
6 Month
-0.06%
-0.06%
1 Year
+9.64%
+9.64%

More News

Read More
Can Momentum Build In Small Caps?
Via Talk Markets
Quarterly & Long-Term Portfolios For The Win
Via Talk Markets
Big Brother Biotechnology Sector Revives
Via Talk Markets
Weekly Visit With The Economy
Via Talk Markets
Topics Economy
Exposures Economy
3 Highly Rated Biotech Stocks for Your July Buy List
Via InvestorPlace
AbbVie Stock: A Perfect Dip for Investors to Buy
Via MarketBeat
Topics ETFs
Tesla And Tech Are Still Taking The Bulls Higher
Via Talk Markets
Biotech Stock Breakout: IBB Eyes Resistance with Amgen and Vertex
Via MarketBeat
Topics ETFs
Exposures COVID-19
Top Performing Industry ETFs In June: Software Leads Returns, Chipmakers Attract Most Inflows
Via Benzinga
Topics ETFs
U.S. Centric Indicators
Via Talk Markets
Rags to Riches: 3 Biotech Stocks That Could Make Early Investors Rich
Via InvestorPlace
Wall Street Favorites: 3 Biotech Stocks With Strong Buy Ratings for June 2024
Via InvestorPlace
One Day Doth Not A Sector Rotation Make
Via Talk Markets
Tech Is Consolidating And The Market’s Seeking New Leadership
Via Talk Markets
Want to Earn More in the Stock Market With Less Effort? Try This Simple Strategy
Via The Motley Fool
Stocks Stall As Chip Sector Struggles To Rebound; Dollar Eyes 7-Week Peak, Gold, Bitcoin Retreat: What's Driving Markets Friday?
Via Benzinga
Gilead Sciences Stock Surges on HIV Treatment Trial Success
Via MarketBeat
Exposures Product Safety
Weekly Update - Sunday, June 16
Via Talk Markets
Thoughts For Thursday: Tech Still Leading
Via Talk Markets
Topics Stocks
Exposures US Equities
Large Cap BIopharmaceuticals Overview
Via Talk Markets
Topics Stocks
Exposures US Equities
Pay No Attention To That Tran Behind The Curtain?
Via Talk Markets
Why the Rest of 2024 Could Be Good for Investing in Biotech Stocks
Via InvestorPlace
Large Cap Biopharmaceuticals Performance
Via Talk Markets
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
B. Riley Financial's diverse suite of services goes beyond traditional financial service offerings. By leveraging cross-platform expertise and assets, B. Riley Financial companies are uniquely positioned to provide full service, collaborative solutions to our clients at every stage of the business life cycle and in all market conditions.

B. Riley refers to B. Riley Financial, Inc. and/or one or more of its subsidiaries or affiliates. Click here for further details.